poisar

Stocks · News reference

Brink's Says Potential NoteMachine/TestLink UK Sale Won't Affect Expected $200M Annual Run-Rate Synergies Within Three Years Of Closing NCR Atleos Deal

BenzingaBenzinga Newsdesk

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referralAcquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — BRINKS CO (BCO)

    Filed: 2026-10-08 AccNo: 0000078890-26-000063 Size: 198 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

  2. Globenewswire IncNa

    Brink's Issues Statement on CMA’s Fast-Track Announcement

    The Brink's Company has agreed to propose divestiture of its NoteMachine/TestLink UK business as a remedy following the UK's Competition and Markets Authority Phase 1 decision on its acquisition of NCR Atleos Corporation. The divestiture was already contemplated in financial metrics and does not impact the expected $200 million in annual run-rate cost synergies. The NCR Atleos acquisition remains on track to close in early Q1 2027, with multiple prospective buyers expressing strong preliminary interest in the divested business.

  3. SEC EDGARSEC EDGAR

    8-K filing — NCR Atleos Corp (NATL)

    Filed: 2026-08-05 AccNo: 0001974138-26-000014 Size: 717 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits